-+ 0.00%
-+ 0.00%
-+ 0.00%

ATARA BIOTHERAPEUTICS INC - PIERRE FABRE TO ASSUME COSTS FOR FDA REMEDIATION TO SUPPORT BLA RESUBMISSION FOR TAB-CEL - SEC FILING

Reuters·04/04/2025 20:32:11

Please log in to view news